Background And Objective: Hyperthermia is performed for prostate cancer. We examined the selective induction of coagulonecrotic changes in the objective area of the canine prostate in enhancing the effect of hyperthermia and treating the target area with transurethral balloon laser enhanced thermotherapy (TUBAL-ET) using a light absorbent material.

Study Design/materials And Methods: The heat exchange of ultrafine carbon particles after laser irradiation was observed in a phantom study using thermography. The carbon solution was injected at the right prostatic lobe in dogs and TUBAL-ET was performed.

Results: The charcoal absorbed the Nd:YAG laser energy and apparently converted it into thermal energy in the phantom study by thermographic observation. TUBAL-ET induced coagulonecrotic changes only at the area at which carbon had been injected in the prostate gland. The necrotic tissue was almost absorbed at four weeks after treatment.

Conclusions: TUBAL-ET induces tissue damage at the target area in the prostate gland.

Download full-text PDF

Source
http://dx.doi.org/10.1002/(sici)1096-9101(1997)21:4<321::aid-lsm3>3.0.co;2-sDOI Listing

Publication Analysis

Top Keywords

transurethral balloon
8
balloon laser
8
laser enhanced
8
enhanced thermotherapy
8
canine prostate
8
coagulonecrotic changes
8
target area
8
phantom study
8
prostate gland
8
prostate
5

Similar Publications

Aim: To investigate the clinical efficacy of transurethral columnar balloon dilation of prostate (TUCBDP) in the treatment of small-volume benign prostatic hyperplasia (BPH) and provide the optimal treatment for the surgical treatment of small volume benign prostatic hyperplasia.

Methods: This retrospective study analyzed 106 patients with small-volume BPH who underwent surgical treatment at the Department of Urology, Xiangya Changde Hospital from December 2023 to January 2024. The patients were divided into two groups based on the type of surgery received: TUCBDP group (n = 53) and transurethral resection of prostate (TURP) group (n = 53), which serves as the control group.

View Article and Find Full Text PDF

Introduction: This study was aimed to evaluate the feasibility, safety, and advantages of the use of transurethral intraprostatic anesthesia (TUIA) using Schelin Catheter (SC) in patients undergoing holmium laser enucleation of the prostate (HoLEP).

Material And Methods: TUIA was performed using SC, a catheter equipped with an operative channel with a retractile needle, a standard drainage outlet, and a balloon port. After inserting the SC into the patient's urethra and filling the balloon to anchor it in the bladder neck, four target injections with local anesthetic were performed, one in each quadrant in the base area of the prostate.

View Article and Find Full Text PDF

Pelvic fracture is a serious injury, which has a profound impact on sexual function due to concurrent nervous and urethral injuries. In this case report, we describe a 29-year-old single man who had retrograde ejaculation as a result of a pelvic fracture-related posterior urethral stricture. The patient wanted to improve his ejaculatory ability after experiencing urethral stricture for 8 years and retrograde ejaculation for 3 years following the pelvic fracture.

View Article and Find Full Text PDF

Objective: To compare the effects of transurethral resection of the prostate (TURP) and transurethral columnar balloon dilatation of the prostate (TUCBDP) in the treatment of BPH.

Methods: This study included 218 BPH patients treated in Qinhuangdao Workers' Hospital from July 2021 to November 2022, 109 by TURP and the other 109 by TUCBDP. We followed up the patients for 12 months, observed their postoperative recovery, complications, serum pain, inflammatory index, cytokine level, urodynamic index, symptom improvement and quality of life (QOL) and compared the data obtained between the two groups of patients.

View Article and Find Full Text PDF

This case report presents the first use of Optilume® drug-coated balloon (DCB) technology for the management of post-transurethral resection of the prostate bladder neck contracture (BNC), a condition often resistant to traditional treatments. A 62-year-old male with recurrent BNC, unresponsive to multiple operative interventions, underwent treatment with the Optilume® DCB, resulting in significant symptom resolution without further invasive procedures. This novel application of DCB technology, delivering paclitaxel directly to the affected tissue, offers a promising alternative by targeting the underlying pathophysiology of BNC.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!